Addus HomeCare Corporation
NASDAQ:ADUSMedical - Care Facilities
+$0.29 today
- Market cap
- $2.25B
- Beta
- 0.90
- P/E (TTM)
- 17.4
- EPS (TTM)
- $5.40
Volume 0.23M
Average 0.25M
ADUS Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Addus HomeCare CorporationNASDAQ: ADUS
Gross Profit · Q2 FY2026 · quarter ended Jun 2026
Gross profit grows, but more slowly than its trailing trend
Q2 FY2026 gross profit of $121.56M rose 6.7% year over year, behind the +15.1% change in trailing-twelve-month gross profit. Sequentially, it rose 4.9% from the prior quarter. Over 3 fiscal years it compounded at +15.5% a year.
Context
- Gross profit amounted to 32.5% of revenue in FY2025, unchanged from a year earlier.
- Gross profit increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +6.7% toward the trailing-twelve-month pace of +15.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 461.87M USD
- Year-over-year change
- +23.2%
- 4-year CAGR
- +14.4%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 461.87M | +23.2% |
| FY2024 | 2024-12-31 | 375.02M | +10.3% |
| FY2023 | 2023-12-31 | 339.88M | +13.4% |
| FY2022 | 2022-12-31 | 299.74M | +11.1% |
| FY2021 | 2021-12-31 | 269.85M | — |
Gross Profit vs competitors
How ADUS compares with its peers on the latest reported figures
- ADUS's LTM Jun 2026 gross profit of $477.75M is the 6th highest of the 7 companies compared; the peer median is $782.94M.
- Its year-over-year change of +15.1% is the 2nd highest of 7, against a peer median of +8.9%.
- Gross profit amounts to 32.4% of revenue for ADUS, versus a peer median of 31.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.72B | +13.3% | +13.5% | 43.9% | |
| LTM Oct 2026 | $858.25M | +12.0% | +13.3% | 32.1% | |
| LTM Jun 2026 | $789.96M | -6.5% | -0.3% | 30.4% | |
| LTM Jun 2026 | $775.91M | +5.9% | +15.6% | 14.1% | |
| LTM Sep 2026 | $506.78M | -12.4% | +15.4% | 32.0% | |
| LTM Jun 2026 | $477.75M | +15.1% | +15.5% | 32.4% | |
| LTM Mar 2026 | $151.28M | +47.4% | +27.9% | 14.8% | |
| Peer median (excluding ADUS) | $782.94M | +8.9% | +14.5% | 31.2% | |
Competitors are the stored peer set for ADUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 864.5M | 951.12M | 1.06B | 1.15B | 1.42B |
| Cost of Revenue | 595.24M | 651.38M | 718.78M | 779.58M | 960.66M |
| Gross Profit | 269.85M | 299.74M | 339.88M | 375.02M | 461.87M |
| Gross Margin | 31.2% | 31.5% | 32.1% | 32.5% | 32.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 189.42M | 216.94M | 231.68M | 258.8M | 306.85M |
| Operating Expenses | 203.32M | 231M | 248.92M | 272.33M | 323.26M |
| Depreciation & Amortization | 14.49M | 14.06M | 14.13M | 13.53M | 16.41M |
| EBITDA | 80.7M | 83.14M | 106.56M | 120.62M | 153.44M |
| EBITDA Margin | 9.3% | 8.7% | 10.1% | 10.4% | 10.8% |
| Operating Income | 65.94M | 68.74M | 90.96M | 102.69M | 138.62M |
| Operating Margin | 7.6% | 7.2% | 8.6% | 8.9% | 9.7% |
| Interest Income | 268K | 341K | 1.48M | 4.39M | 1.59M |
| Interest Expense | 5.81M | 8.91M | 11.11M | 7.73M | 9.58M |
| Other Income / Expenses | (5.54M) | (8.57M) | (9.63M) | (3.34M) | (11.17M) |
| Income Before Tax | 60.4M | 60.17M | 81.33M | 99.35M | 127.45M |
| Pre-Tax Margin | 7.0% | 6.3% | 7.7% | 8.6% | 9.0% |
| Income Tax Expense | 15.27M | 14.15M | 18.81M | 25.76M | 31.54M |
| Net Income | 45.13M | 46.03M | 62.52M | 73.6M | 95.91M |
| Net Margin | 5.2% | 4.8% | 5.9% | 6.4% | 6.7% |
| EPS (Basic) | 2.87 | 2.90 | 3.91 | 4.33 | 5.19 |
| EPS (Diluted) | 2.81 | 2.84 | 3.83 | 4.23 | 5.21 |
| Weighted Avg Shares | 15.74M | 16.13M | 16.23M | 17.01M | 18.45M |
| Weighted Avg Shares (Diluted) | 16.06M | 16.18M | 16.31M | 17.38M | 18.45M |
Addus HomeCare Corporation
NASDAQ:ADUS
Intrinsic Alpha fair value
Locked
Current Price
$120.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.